Clinical trialNCT02794870CompletedPhase 1Interventional

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment33Respiratory Syncytial Virus Infections

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study was to evaluate the safety, infectivity, and immunogenicity of a single dose of a recombinant live-attenuated respiratory syncytial virus (RSV) vaccine in RSV-seronegative infants 6 to 24 months of age. This study was a companion study to CIR 311.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Elizabeth J. McFarland, MD
Children's Hospital Colorado Pediatric Infectious Diseases
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, Uc San Diego Crs- Mother-Child-Adolescent Hiv Program
La Jolla, California, United States
Usc la Nichd Crs
Los Angeles, California, United States
Univ. of Colorado Denver Nichd Crs
Aurora, Colorado, United States
Lurie Children'S Hospital of Chicago (lch) Crs
Chicago, Illinois, United States
Rush Univ. Cook County Hosp. Chicago Nichd Crs
Chicago, Illinois, United States
Johns Hopkins University Center for Immunization Research
Baltimore, Maryland, United States
Suny Stony Brook Nichd Crs
Stony Brook, New York, United States
Jacobi Med. Ctr. Bronx Nichd Crs
The Bronx, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboRSV LID ΔM2-2 1030s vaccine

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Jul 2016
Primary completion: 7 Jul 2017
Completion: 7 Jul 2017
Last update posted: 27 Aug 2018
Registered enrollment: 33
Registry id: NCT02794870

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.